European Archives - Page 902 of 1371 - European Medical Journal

EMJ Podcast: 2020 Vision in IBD

This episode provides an overview of the symposium ‘20 20 Vision in IBD’ from ECCO. Listen now for more details

EMJ Podcast: Managing AF Patients with ACS and/or Undergoing PCI

In this episode Jonathan Sackier chats to Dr Amit Vora from Duke University about the results of the AUGUSTUS trial.

Credit Card-Sized Tool to Grow Cancer Cells Outside of the Human Body

INVASION and metastasis of tumour cells poses a significant challenge in cancer treatment; in the face of growing concerns, a team at

Is Immunotherapy Safe for COVID-19 Patients?

COMORBID COVID-19 and cancer is complicated by immunotherapy treatment, which activates an immune system response that may already be overactive

Interview: Prof Hamid Rabb

Prof Hamid Rabb | Professor of Medicine and Medical Director of the Johns Hopkins Kidney Transplant Program…

The Association Between Cystatin C and Arterial Stiffness in Non-Chronic Kidney Disease Patients

Serum cystatin C (cysC) is a protease inhibitor with a low molecular weight, which is produced by all nucleated cells at a constant rate…

EMJ Nephrology 8.1 2020

This ejournal contains high quality peer-reviewed articles, a review of the ERA-EDTA Virtual Congress 2020…

Review of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress 2020

CAPITAL of Lombardy, one of the world’s four fashion capitals, and unparalleled collector of works by Leonardo da Vinci, Michelangelo, and Caravaggio…

Digital Education for Patients with Chronic Kidney Disease: The Renal Health Project Experience

Chronic kidney disease (CKD) is a growing problem in many parts of the world, with >700 million people affected.1 One of the main challenges in the…

Editor’s Pick: New Aspects of Pathogenesis and Treatment of Membranous Glomerulopathy After the MENTOR Study

Membranous nephropathy (MN) is the major cause of nephrotic syndrome in adults, accounting for 20% of cases with an annual incidence of 1 per 100,000 population.